Clinical Genome Sequencing (CLIA / CAP)
Clinical Genome Sequencing provides a CLIA-validated comprehensive analysis of the entire genome to uncover mutations in coding and non-coding regions, including structural and copy number variants.
Clinical Genome Sequencing provides a CLIA-validated comprehensive analysis of the entire genome to uncover mutations in coding and non-coding regions, including structural and copy number variants.
GENEWIZ from Azenta Life Sciences combined regulatory services support your preclinical and clinical regulatory submissions. Our US laboratories are GLP and CLIA compliant and CAP accredited.